High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS 1 R Ligands
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c01701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Fabian J Ertl und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany. Hauptthemen laut MEDLINE: Receptors, Neurotensin, Fluorescent Dyes, Neurotensin, Peptides. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Bayerisches Zentrum f?r Krebsforschung (BZKF).
Abstract (Originalsprache)
Labeled ligands for the neurotensin receptor 1 (NTS1R), which is expressed in the CNS, the gastrointestinal tract, and in malignant tumors, are needed to investigate NTS1R-ligand binding and NTS1R expression. Aiming for fluorescence-labeled neurotensin(8-13)-derived NTS1R ligands with high affinity and proteolytic stability, several previous approaches were combined: (1) replacement of Arg8 by an amino-functionalized carbamoylated arginine, allowing conjugation to a fluorophore, (2) Nα-methylation of Arg8 and replacement of Tyr by β,β-dimethyl-l-Tyr11, conferring proteolytic stability, and (3) replacement of Leu13 by trimethylsilyl-Ala, boosting binding affinity. This strategy gave fluorescent NTS1R ligands with unprecedented NTS1R binding affinity (5-TAMRA-labeled ligand 19: Ki 0.14 nM, sulfo-Cy5-labeled probe 21: Ki 0.094 nM) and high stability in human plasma (t1/2 ≫ 48 h). Their suitability for competition binding studies (flow cytometry; 19, 21) and the imaging of NTS1R expression in living cells (confocal microscopy, biomolecular imaging; 19, 21) and tumor tissue (biomolecular imaging; 21) is demonstrated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany.
- Bavarian Cancer Research Center (BZKF), Translational Research Group TRAFO, Franz-Josef-Strauß-Allee 11, Regensburg D-93053, Germany.
- Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, Erlangen D-91054, Germany.
- Bavarian Cancer Research Center (BZKF), Translational Research Group TRAFO, Kussmaulallee 12, D-91054 Erlangen, Germany.
- Institute of Biophysics and Physical Biochemistry, Faculty of Biology and Preclinical Medicine, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany.
- Institute of Physical and Theoretical Chemistry, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany.
ORCID-Profile: Fabian J Ertl, Nataliya Archipowa, Pierre Koch, Simone Maschauer, Olaf Prante, Max Keller
Förderung
- Deutsche Forschungsgemeinschaft
- Bayerisches Zentrum f?r Krebsforschung (BZKF)
Zitieren
APA
Ertl, F. J., Friedel, A., Schmid, E. J., Höring, C., Archipowa, N., Koch, P., Maschauer, S., Kutta, R. J., Prante, O., & Keller, M. (2025). High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS 1 R Ligands. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01701
Vancouver
Ertl FJ, Friedel A, Schmid EJ, Höring C, Archipowa N, Koch P, et al. High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS 1 R Ligands. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01701
BibTeX
@article{Ertl2025,
author = {Ertl, Fabian J and Friedel, Anna and Schmid, Elena J and Höring, Carina and Archipowa, Nataliya and Koch, Pierre and Maschauer, Simone and Kutta, Roger J and Prante, Olaf and Keller, Max},
title = {High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS 1 R Ligands},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c01701}
}
EUVIMED